-
Luxa Doses First Participant in Clinical Trial of RPE Stem Cells for Dry AMD Patients
Eye On the Cure Research News -
Beacon Stories
-
Foundation Insights Forum – May 13, 2022
Insights Forum
-
AGTC’s XLRP Gene Therapy Performs Well in Extension of Phase 2 Clinical Trial
Eye On the Cure Research News -
Foundation Podcasts

Our Track Record
The Foundation is committed to finding treatments and cures for people affected by blinding retinal diseases.
-
1st gene therapy
for any inherited disease to be approved by the FDA
learn more -
$856M dollars raised
since 1971
learn more -
35 VisionWalk events
throughout the United States
learn more -
87 grants awarded
in 2021 – over 109 investigators, 70 institutions
Learn more
The Foundation in the News
Luxa Doses First Participant in Clinical Trial of RPE Stem Cells for Dry AMD Patients
Eye On the Cure Research News-
May 23, 2022Beacon Stories
-
May 19, 2022
ProQR’s Sepofarsen Improves Vision Significantly for Girl with LCA10
Eye On the Cure Research News -
May 17, 2022
AGTC’s XLRP Gene Therapy Performs Well in Extension of Phase 2 Clinical Trial
Eye On the Cure Research News

Living with vision loss can be difficult, but you don't have to do it alone
View local chaptersGet Involved
-
Take important steps toward a cure by participating in a 5k VisionWalk
Join a Walk -
Join people coming together to find a cure from all over the country
Search Our Events -
Make a difference today and support promising research by donating a one-time gift
Donate Now